Home › Funds › Vitruvian Partners LLP › MXCT
Vitruvian Partners LLP position in MXCT
MAXCYTE INC · Health Care
Vitruvian Partners LLP reported holding 5,043,356 shares of MXCT (MAXCYTE INC) in its Q3 2026 13F filing — a position valued at US$5.6M, representing 4.99% of its reported portfolio and ranking #6 among its reported holdings. Vitruvian Partners LLP has disclosed MXCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Vitruvian Partners LLP's MXCT position evolved
Vitruvian Partners LLP first disclosed a stake in MXCT in Q3 2023 at 5,043,356 shares (US$15.7M). The position peaked in Q4 2023 at 5,043,356 shares, worth US$23.7M. Across 13 filings, Vitruvian Partners LLP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 5,043,356 shares valued at US$5.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.04M | $15.74M | New |
| Q4 2023 | 5.04M | $23.70M | Hold |
| Q1 2024 | 5.04M | $21.13M | Hold |
| Q2 2024 | 5.04M | $19.77M | Hold |
| Q3 2024 | 5.04M | $19.62M | Hold |
| Q4 2024 | 5.04M | $20.98M | Hold |
| Q1 2025 | 5.04M | $13.77M | Hold |
| Q2 2025 | 5.04M | $10.99M | Hold |
| Q3 2025 | 5.04M | $7.97M | Hold |
| Q4 2025 | 5.04M | $7.82M | Hold |
| Q1 2026 | 5.04M | $3.54M | Hold |
| Q2 2026 | 5.04M | $6.20M | Hold |
| Q3 2026 | 5.04M | $5.65M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MXCT and 13F data
MXCT (MAXCYTE INC) is a Health Care company. 22 other funds we track also report a position in MXCT — the largest reported positions include Capricorn Fund Managers Ltd (US$9.2M), Mudita Advisors LLP (US$4.1M), CADIAN CAPITAL MANAGEMENT, LP (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MXCT
- Capricorn Fund Managers Ltd 8.20M sh · $9.18M · Q3 2026
- Mudita Advisors LLP 3.37M sh · $4.15M · Q2 2026
- CADIAN CAPITAL MANAGEMENT, LP 2.20M sh · $2.71M · Q2 2026
- Peapod Lane Capital LLC 1.98M sh · $2.22M · Q3 2026
- Brooklands Fund Management Ltd 1.56M sh · $1.75M · Q3 2026
- NANO CAP NEW MILLENNIUM GROWTH FUND L P 1.20M sh · $1.48M · Q2 2026
More on Vitruvian Partners LLP
FAQ
How long has Vitruvian Partners LLP held MXCT?
Vitruvian Partners LLP has disclosed MXCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Vitruvian Partners LLP's current position in MXCT?
As of Q3 2026, Vitruvian Partners LLP holds 5.04M shares of MXCT (MAXCYTE INC), valued at $5.65M, representing 4.99% of its reported portfolio and ranking #6.
Has Vitruvian Partners LLP been buying or selling MXCT?
In the latest 13F filing (Q3 2026), Vitruvian Partners LLP held unchanged its position in MXCT. The position peaked in Q4 2023 at 5.04M shares.
Which other funds hold MXCT?
Other major institutional holders of MXCT include Capricorn Fund Managers Ltd, Mudita Advisors LLP, CADIAN CAPITAL MANAGEMENT, LP, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.